3rd Quarter - Report

MARS, INCORPORATED for MARS, INCORPORATED

Firm
Client
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade issues, including NAFTA, China and other international trade issues; Legislative proposals related to U.S. sanction policies, to ensure Congress understands impacts on the operations of U.S. companies in Russia.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: Labor, Dept of (DOL); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Food Industry (safety, labeling, etc.) FOO

Supporting FDA voluntary guidance on sodium; Supporting timely implementation of Nutrition Fact Panel; Preventative oral health; Food ingredient policy; Dietary guidelines; Food Safety Modernization Act (FSMA) funding.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: Food & Drug Administration (FDA); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE; Health & Human Services, Dept of (HHS)

Energy/Nuclear ENG

Issues related to energy savings and climate change, including U.S. support for Paris Climate Agreement, carbon pricing and EPAs Clean Power Plan.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); SENATE; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES

Agriculture AGR

Development of national standard on GMO labeling; Farm Bill policies, including sugar availability and policy reforms, and Supplemental Nutrition Assistance Program (SNAP) reauthorization; Appropriations funding for international aid and development programs, including ILAB and USAID; Funding for conservation programs; Support for WHO and private sector collaborations to achieve positive outcomes for public health and safety.

LobbyistCovered position, as disclosed
BRAD G FIGEL —
PETER ROWAN —

Contacted: Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.